Low vitamin D levels accelerates muscle mass loss in patients with chronic liver disease. by Tomomi Okubo, Masanori Atsukawa, Akihito Tsubota, Hiroki Ono, Tadamichi Kawano, Yuji Yoshida, Taeang Arai, Korenobou Hayama, Norio Itokawa, Chisa Kondo, Katsuhiko Iwakiri

Get full text

Low vitamin D levels accelerates muscle mass loss in patients with chronic liver disease by Tomomi Okubo, Masanori Atsukawa, Akihito Tsubota, Hiroki Ono, Tadamichi Kawano, Yuji Yoshida, Taeang Arai, Korenobou Hayama, Norio Itokawa, Chisa Kondo, Katsuhiko Iwakiri

Get full text

A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C by Yuji Yoshida, Masanori Atsukawa, Chisa Kondo, Michika Kitamura, Kaori Shioda-Koyano, Tadamichi Kawano, Hiroki Ono, Korenobu Hayama, Tomomi Okubo, Taeang Arai, Norio Itokawa, Katsuhiko Iwakiri

Get full text

A novel formula used for predicting hepatocellular carcinoma after the achievement of sustained virologic response by direct-acting antivirals in patients with chronic hepatitis C. by Yuji Yoshida, Masanori Atsukawa, Chisa Kondo, Michika Kitamura, Kaori Shioda-Koyano, Tadamichi Kawano, Hiroki Ono, Korenobu Hayama, Tomomi Okubo, Taeang Arai, Norio Itokawa, Katsuhiko Iwakiri

Get full text

How do the 2022 European Society of Cardiology/European Respiratory Society guidelines modify the diagnosis of portopulmonary hypertension in patients with cirrhosis complicated by... by Masanori Atsukawa, Akihito Tsubota, Yuichi Tamura, Kaori Koyano‐Shioda, Tadamichi Kawano, Tomomi Okubo, Korenobu Hayama, Taeang Arai, Norio Itokawa, Yu Taniguchi, Yudai Tamura, Chisa Kondo, Katsuhiko Iwakiri

Get full text

Efficacy and safety of oral semaglutide in patients with non‐alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study by Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Hirotaka Ono, Tadamichi Kawano, Yuji Yoshida, Tomomi Okubo, Korenobu Hayama, Ai Nakagawa‐Iwashita, Norio Itokawa, Chisa Kondo, Mototsugu Nagao, Katsuhiko Iwakiri

Get full text

Impact of pemafibrate in patients with metabolic dysfunction‐associated steatotic liver disease complicated by dyslipidemia: A single‐arm prospective study by Hiroki Ono, Masanori Atsukawa, Akihito Tsubota, Taeang Arai, Kenta Suzuki, Tetsuyuki Higashi, Michika Kitamura, Kaori Shioda‐Koyano, Tadamichi Kawano, Yuji Yoshida, Tomomi Okubo, Korenobu Hayama, Norio Itokawa, Chisa Kondo, Mototsugu Nagao, Masato Iwabu, Katsuhiko Iwakiri

Get full text

Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease by Tadamichi Kawano, Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hidenori Toyoda, Koichi Takaguchi, Joji Tani, Asahiro Morishita, Atsushi Hiraoka, Shigeru Mikami, Toru Ishikawa, Hironao Okubo, Tsunamasa Watanabe, Tomomi Okubo, Taeang Arai, Korenobu Hayama, Norio Itokawa, Chisa Kondo, Katsuhiko Iwakiri

Get full text

Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus by Taeang Arai, Masanori Atsukawa, Akihito Tsubota, Shigeru Mikami, Uojima Haruki, Keiichiro Yoshikata, Hiroki Ono, Tadamichi Kawano, Yuji Yoshida, Tomohide Tanabe, Tomomi Okubo, Korenobu Hayama, Ai Nakagawa‐Iwashita, Norio Itokawa, Chisa Kondo, Keiko Kaneko, Mototsugu Nagao, Kyoko Inagaki, Izumi Fukuda, Hitoshi Sugihara, Katsuhiko Iwakiri

Get full text